Cargando…

Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases

BACKGROUND: The purpose of this study was to evaluate the diagnostic value of combined virtual bronchoscopic navigation (Direct Path), radial endobronchial ultrasound with guide-sheath (EBUS), ultrathin bronchoscopy, rapid on-site evaluation of cytology (ROSE), and metagenomic next-generation sequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Nana, Kan, Jianying, Yu, Naihao, Cao, Wenbin, Cao, Jie, Jiang, Erlie, Feng, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798119/
https://www.ncbi.nlm.nih.gov/pubmed/35117891
http://dx.doi.org/10.21037/tcr-20-604
_version_ 1784641722114899968
author Liu, Nana
Kan, Jianying
Yu, Naihao
Cao, Wenbin
Cao, Jie
Jiang, Erlie
Feng, Jing
author_facet Liu, Nana
Kan, Jianying
Yu, Naihao
Cao, Wenbin
Cao, Jie
Jiang, Erlie
Feng, Jing
author_sort Liu, Nana
collection PubMed
description BACKGROUND: The purpose of this study was to evaluate the diagnostic value of combined virtual bronchoscopic navigation (Direct Path), radial endobronchial ultrasound with guide-sheath (EBUS), ultrathin bronchoscopy, rapid on-site evaluation of cytology (ROSE), and metagenomic next-generation sequencing (mNGS) for difficult lung lesions in patients with haematological diseases. METHODS: In this study, lung specimens were obtained from patients with haematological diseases by transbronchial lung biopsy (TBLB) and bronchoalveolar lavage (BAL). The specimens were subjected to mNGS for sequencing of pathogenic microorganisms and sent to the laboratory for examination and pathological analysis. Additionally, the clinical data and pathogenic characteristics of the patients were analysed. The sensitivity and specificity of mNGS for sequencing pathogenic microorganisms were compared between TBLB and BAL specimens. RESULTS: In this study, the diagnosis of infectious pneumonia mainly included cytomegalovirus pneumonia, Pneumocystis jirovecii pneumonia (PCP), pulmonary aspergillosis, and tuberculosis. Some patients had non-infectious pulmonary complications, and the clinical and therapeutic outcomes were diagnosed as graft-versus-host disease (GVHD), idiopathic pneumonia syndrome (IPS), and delayed pulmonary toxicity syndrome (DPTS). The sensitivity of mNGS for pathogenic microbes in lung tissue is better than that of alveolar lavage fluid, whereas compared with alveolar lavage fluid, its specificity is reduced. CONCLUSIONS: The results of this study indicate that combined virtual bronchoscopic navigation (Direct Path), radial EBUS, ultrathin bronchoscopy, and ROSE of target control specimens reduce the risk of bleeding, and their combination with mNGS has high diagnostic value for difficult lung lesions in patients with haematological diseases, especially in the field of infection diagnosis. TBLB and BAL specimens have respective advantages in specificity and sensitivity for mNGS analysis.
format Online
Article
Text
id pubmed-8798119
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87981192022-02-02 Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases Liu, Nana Kan, Jianying Yu, Naihao Cao, Wenbin Cao, Jie Jiang, Erlie Feng, Jing Transl Cancer Res Original Article BACKGROUND: The purpose of this study was to evaluate the diagnostic value of combined virtual bronchoscopic navigation (Direct Path), radial endobronchial ultrasound with guide-sheath (EBUS), ultrathin bronchoscopy, rapid on-site evaluation of cytology (ROSE), and metagenomic next-generation sequencing (mNGS) for difficult lung lesions in patients with haematological diseases. METHODS: In this study, lung specimens were obtained from patients with haematological diseases by transbronchial lung biopsy (TBLB) and bronchoalveolar lavage (BAL). The specimens were subjected to mNGS for sequencing of pathogenic microorganisms and sent to the laboratory for examination and pathological analysis. Additionally, the clinical data and pathogenic characteristics of the patients were analysed. The sensitivity and specificity of mNGS for sequencing pathogenic microorganisms were compared between TBLB and BAL specimens. RESULTS: In this study, the diagnosis of infectious pneumonia mainly included cytomegalovirus pneumonia, Pneumocystis jirovecii pneumonia (PCP), pulmonary aspergillosis, and tuberculosis. Some patients had non-infectious pulmonary complications, and the clinical and therapeutic outcomes were diagnosed as graft-versus-host disease (GVHD), idiopathic pneumonia syndrome (IPS), and delayed pulmonary toxicity syndrome (DPTS). The sensitivity of mNGS for pathogenic microbes in lung tissue is better than that of alveolar lavage fluid, whereas compared with alveolar lavage fluid, its specificity is reduced. CONCLUSIONS: The results of this study indicate that combined virtual bronchoscopic navigation (Direct Path), radial EBUS, ultrathin bronchoscopy, and ROSE of target control specimens reduce the risk of bleeding, and their combination with mNGS has high diagnostic value for difficult lung lesions in patients with haematological diseases, especially in the field of infection diagnosis. TBLB and BAL specimens have respective advantages in specificity and sensitivity for mNGS analysis. AME Publishing Company 2020-09 /pmc/articles/PMC8798119/ /pubmed/35117891 http://dx.doi.org/10.21037/tcr-20-604 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Liu, Nana
Kan, Jianying
Yu, Naihao
Cao, Wenbin
Cao, Jie
Jiang, Erlie
Feng, Jing
Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases
title Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases
title_full Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases
title_fullStr Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases
title_full_unstemmed Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases
title_short Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases
title_sort application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798119/
https://www.ncbi.nlm.nih.gov/pubmed/35117891
http://dx.doi.org/10.21037/tcr-20-604
work_keys_str_mv AT liunana applicationofmetagenomicnextgenerationsequencingtechnologyfordifficultlunglesionsinpatientswithhaematologicaldiseases
AT kanjianying applicationofmetagenomicnextgenerationsequencingtechnologyfordifficultlunglesionsinpatientswithhaematologicaldiseases
AT yunaihao applicationofmetagenomicnextgenerationsequencingtechnologyfordifficultlunglesionsinpatientswithhaematologicaldiseases
AT caowenbin applicationofmetagenomicnextgenerationsequencingtechnologyfordifficultlunglesionsinpatientswithhaematologicaldiseases
AT caojie applicationofmetagenomicnextgenerationsequencingtechnologyfordifficultlunglesionsinpatientswithhaematologicaldiseases
AT jiangerlie applicationofmetagenomicnextgenerationsequencingtechnologyfordifficultlunglesionsinpatientswithhaematologicaldiseases
AT fengjing applicationofmetagenomicnextgenerationsequencingtechnologyfordifficultlunglesionsinpatientswithhaematologicaldiseases